Medanta- Pahwa x tweetsMedanta- Pahwa x tweets
1) 320 Concept following
2) One more retest / Consolidation needed
3) Lets see
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
17.95 INR
4.78 B INR
32.48 B INR
83.05 M
About GLOBAL HEALTH LTD
Sector
Industry
CEO
Pankaj Prakash Sahni
Website
Headquarters
Gurugram
Founded
2004
ISIN
INE474Q01031
FIGI
BBG01B6TW7B1
Global Health Ltd. engages in the provision of healthcare, pathology, and other medical services. It engages in the research and development activities related to drugs, surgery, medical devices and equipment. The company was founded on August 13, 2004 and is headquartered in Gurugram, India.
Medanta - Solid business, solid price chartAfter completing a long correction Medanta is ready for a strong rally
The business is also every growing
Medanta in demand zoneThe stock has reached its demand zone where it is possible that stock reverse its downward journey and move upside. Possible targets 1150 then 1250.
Pullback Trade in Global Health Ltd (MEDANTA)Stock Analysis
Global Health Ltd (MEDANTA) is forming a double bottom pattern.
This setup offers a very favorable risk to reward ratio.
Trading Strategy
Entry Point: Look for a breakout above the 1500 level.
Target and Stop Loss: Levels are plotted on the chart for guidance.
Stop Loss
MEDANTA - Compressing for a explosive move ?We can see Contraction in
Volatility
Volume
Spread
Also we see clustering of Closes. The spring is being compressed for a explosive move. Probability seems to favor a move on the upper side.
ATH breakout #Medanta
Breakout abv 735.
- Constructive Base.
-Higer Relative Strength.
- Price inching towards bluesky.
- Growth YOY
Sales
25.2 %
Profit
73.8 %
-InstHold
21.4 %
MEDANTA Neat and clean breakout with retest seems to be completed in MEDANTA ..
FII Holdings near 10%
Cmp 490
Sl below 470
TGT 530 then trail SL
Note: Just an idea not any recommendation to buy or sell any security holdings ..
MEDANTA Trading above breakout levelWait for retrace, near 490 to 495
First Target will be 430
Stop loss below trend line weekly basis.
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MEDANTA is 1,067.75 INR — it has decreased by −1.59% in the past 24 hours. Watch GLOBAL HEALTH LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange GLOBAL HEALTH LTD stocks are traded under the ticker MEDANTA.
MEDANTA stock has fallen by −4.23% compared to the previous week, the month change is a 7.20% rise, over the last year GLOBAL HEALTH LTD has showed a 27.91% increase.
We've gathered analysts' opinions on GLOBAL HEALTH LTD future price: according to them, MEDANTA price has a max estimate of 1,400.00 INR and a min estimate of 895.00 INR. Watch MEDANTA chart and read a more detailed GLOBAL HEALTH LTD stock forecast: see what analysts think of GLOBAL HEALTH LTD and suggest that you do with its stocks.
MEDANTA reached its all-time high on Feb 16, 2024 with the price of 1,513.90 INR, and its all-time low was 390.55 INR and was reached on Nov 16, 2022. View more price dynamics on MEDANTA chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MEDANTA stock is 3.00% volatile and has beta coefficient of 0.42. Track GLOBAL HEALTH LTD stock price on the chart and check out the list of the most volatile stocks — is GLOBAL HEALTH LTD there?
Today GLOBAL HEALTH LTD has the market capitalization of 286.77 B, it has increased by 1.57% over the last week.
Yes, you can track GLOBAL HEALTH LTD financials in yearly and quarterly reports right on TradingView.
GLOBAL HEALTH LTD is going to release the next earnings report on Nov 11, 2024. Keep track of upcoming events with our Earnings Calendar.
MEDANTA earnings for the last quarter are 4.00 INR per share, whereas the estimation was 4.60 INR resulting in a −13.04% surprise. The estimated earnings for the next quarter are 4.40 INR per share. See more details about GLOBAL HEALTH LTD earnings.
GLOBAL HEALTH LTD revenue for the last quarter amounts to 8.61 B INR, despite the estimated figure of 8.56 B INR. In the next quarter, revenue is expected to reach 9.03 B INR.
MEDANTA net income for the last quarter is 1.06 B INR, while the quarter before that showed 1.27 B INR of net income which accounts for −16.56% change. Track more GLOBAL HEALTH LTD financial stats to get the full picture.
No, MEDANTA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 10.78 K employees. See our rating of the largest employees — is GLOBAL HEALTH LTD on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GLOBAL HEALTH LTD EBITDA is 8.18 B INR, and current EBITDA margin is 25.49%. See more stats in GLOBAL HEALTH LTD financial statements.
Like other stocks, MEDANTA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GLOBAL HEALTH LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GLOBAL HEALTH LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GLOBAL HEALTH LTD stock shows the neutral signal. See more of GLOBAL HEALTH LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.